Depomed’s Lawsuits Against Watson Laboratories, Par Pharmaceutical Dismissed

Depomed’s lawsuits against Watson Laboratories and Par Pharmaceutical in relation to Abbreviated New Drug Applications for Gralise (gabapentin) have been dismissed.
Pharmaceutical Business Review